MedImmune parent, Amgen launch partnership – Gazette.Net: Maryland Community News Online


Telegraph.co.uk

MedImmune parent, Amgen launch partnership
Gazette.Net: Maryland Community News Online
AstraZeneca is to lead the development and commercial strategy of three candidates, AMG 139, AMG 157 and AMG 181, which are being studied to treat Crohn's disease, asthma and ulcerative colitis, respectively. Amgen will spearhead efforts regarding
Amgen and AstraZeneca Announce Collaboration to Jointly Develop and PR Newswire (press release)
Big Pharma Buys Access To This Promising Biotech PipelineMotley Fool UK
AstraZeneca, Amgen enter into development and commercialization agreementPharmaceutical Business Review
FierceBiotech –Washington Business Journal –Reuters UK
all 11 news articles »

View full post on asthma – Google News

Maryland Plans to End Health Disparities – Patch.com


msnbc.com

Maryland Plans to End Health Disparities
Patch.com
"When you look at the African-American asthma rate, it's much higher than the white population's rate or when you look at the Asian Pacific Islanders' liver cancer rate, it's three times the rate of the population at large," said Cardin.
Health Highlights: April 8, 2011U.S. News & World Report
US Moves to Reduce Health DisparitiesNational Journal
Govt announces plan to reduce health disparitiesFox News

all 366 news articles »

View full post on asthma – Google News